Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

This study is not yet open for participant recruitment.

Study NCT01469338 Information provided by USC/Norris Comprehensive Cancer Center

First Received: November 1, 2011 Last Updated: May 15, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	October 2015
Estimated Primary Completion Date:	October 2014 (Final data collection date for primary outcome measure)